BOLT - Bolt Biotherapeutics GAAP EPS of -$0.53 beats by $0.05 revenue of $1.41M misses by $0.13M March, 29 2023 04:55 PM Bolt Biotherapeutics Inc. 2023-03-29 16:55:11 ET Bolt Biotherapeutics press release ( NASDAQ: BOLT ): Q4 GAAP EPS of -$0.53 beats by $0.05 . Revenue of $1.41M (+176.5% Y/Y) misses by $0.13M . For further details see: Bolt Biotherapeutics GAAP EPS of -$0.53 beats by $0.05, revenue of $1.41M misses by $0.13M